Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children

Clinical trial NCT01266993 · COMPLETED

Trial details

NCT number: NCT01266993
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Meningococcal Meningococcal Vaccines

Start date: 2011-01-03
Primary completion: 2014-03-31
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.